# OnCo record nct07724756 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07724756/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07724756", "NCT07724756" ;
  schema:name "Phase II Study of QLC2519 in Pediatric Solid Tumor Participants"@en ;
  schema:description "A phase 2 trial of Albipagrastim alf in childhood cancers, run by Qilu Pharmaceutical Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07724756/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07724756> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2026-06-26" ;
  onco:cancers <https://onco.cc/cancers/childhood-cancers/> ;
  onco:companies <https://onco.cc/companies/qilu-pharmaceutical/> .